Low
₹7,039.90
High
₹7,064.00
Low
₹6,162.95
High
₹7,291.95
| Previous Close | ₹7,012.30 |
|---|---|
| Day's Range | ₹7,039.90 - ₹7,064.00 |
| Open | ₹7,058.90 |
| 52 Week Range | ₹6,162.95 - ₹7,291.95 |
| Volume | 39,87,49,976 |
| Company Name | LTP (₹) | Change (₹) | Sector |
|---|---|---|---|
| Amara Raja Energy & Mobility Ltd. | 930.35 | |
Automobile & Ancillaries |
| Atul Ltd. | 6555.00 | |
Chemicals |
| Force Motors Ltd. | 17921.00 | |
Automobile & Ancillaries |
| Bata India Ltd. | 712.35 | |
FMCG |
| Blue Star Ltd. | 1524.40 | |
Consumer Durables |
| Chambal Fertilisers and Chemicals Ltd. | 434.80 | |
Chemicals |
| Exide Industries Ltd. | 459.60 | |
Automobile & Ancillaries |
| Cipla Ltd. | 1438.00 | |
Healthcare |
| CRISIL Ltd. | 4485.60 | |
Ratings |
| CG Power and Industrial Solutions Ltd. | 872.10 | |
Capital Goods |
| Index Name | Market Value | 52W High | 52W Low |
|---|---|---|---|
| Nifty 50 | 24236.6 | 26373.20 | 22182.55 |
| Nifty IT | 30731.0 | 40301.40 | 25699.10 |
| Nifty Next 50 | 74186.15 | 74878.45 | 59896.10 |
| NIFTY50 USD Index | 8774.95 | 10443.40 | 8132.40 |
| Nifty Bank | 57554.8 | 61764.85 | 49954.85 |
| NIFTY Midcap 100 | 63811.85 | 64139.05 | 52032.85 |
| Nifty 500 | 23531.4 | 24144.20 | 20385.65 |
| Nifty Midcap 50 | 18341.85 | 18403.50 | 14804.55 |
| Nifty 100 | 25395.0 | 26975.15 | 22720.45 |
| Nifty FMCG | 47818.7 | 58485.05 | 45334.15 |
With reference to its disclosure having Ref. No. COSEC/077/2026-27 dated 17th August 2026 regarding the execution of Definitive Agreement i.e., Securities Purchase Agreement by Axiro Semiconductor, Wholly Owned Subsidiary of the company for the acquisition of 100% of the shareholding in Tosil Systems (‘Tosil’) for a consideration of Rs. 16.44 Crores. Further to the above, CG Power and Industrial Solutions has informed that Axiro has completed the acquisition today of 5,00,000 equity shares of the face value of Rs.10/- each, representing 100% of the subscribed and paid-up equity share capital of Tosil. Consequently, Tosil has become a Wholly Owned Subsidiary of Axiro under Section 2(87) of the Companies Act, 2013.
The above information is a part of company’s filings submitted to BSE.
Glenmark Pharmaceuticals has informed that, Glenmark Pharmaceuticals (Glenmark) today announced the receipt of U.S. FDA approval1 for Fluticasone Propionate Nasal Spray USP, 0.05 mg/spray. Glenmark’s Fluticasone Propionate Nasal Spray USP is bioequivalent and therapeutically equivalent to the reference listed drug, Flonase®2 Nasal Spray, 0.05 mg/spray of Haleon US Holdings LLC [NDA 020121] and will be distributed in the U.S. by Glenmark Pharmaceuticals Inc., USA. The company has attached media release.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The previous close of SHARIAH500 index is ₹7051.9 as of 2026-08-20.
The total volume of SHARIAH500 index is 398749976.00 as of 2026-08-20.
The percentage change in value of SHARIAH500 index is 0.56% as of 2026-08-20.
The absolute increase in SHARIAH500 index value since the previous trading day is ₹39.6 as of 2026-08-20.
A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.
A Shariah Index tracks companies that comply with defined Islamic investment principles. It excludes businesses engaged in activities that do not meet Shariah screening standards and applies financial and business activity filters.
The Nifty 500 Shariah Index is derived from the Nifty 500 universe and includes only companies that satisfy Shariah-compliance requirements. It serves as a benchmark for tracking the performance of eligible stocks under Islamic screening criteria.
Stocks are selected from the Nifty 500 universe after applying business activity and financial screening criteria designed to identify companies that comply with recognised Shariah investment principles.
The Nifty 500 Shariah Index is managed by NSE Indices Limited. The index provider conducts periodic reviews to ensure that constituent companies continue to meet the prescribed eligibility and compliance requirements.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.